Equities

Wilk Technologies Ltd

WILK:TLV

Wilk Technologies Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (ILa)44.30
  • Today's Change-1.40 / -3.06%
  • Shares traded116.02k
  • 1 Year change-58.87%
  • Beta0.8166
Data delayed at least 20 minutes, as of Sep 26 2024 15:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Wilk Technologies Ltd, formerly known as Biomilk Ltd, is an Israel-based biotechnology company. The Company researches and develops the production processes of farmed milk and its products as a substitute for animal milk and for mother's milk. It expects to create sour milk production systems in 2023.

  • Revenue in ILS (TTM)0.00
  • Net income in ILS-9.52m
  • Incorporated1986
  • Employees4.00
  • Location
    Wilk Technologies LtdProf. Hillel i Hanan Oppenheimer 2REHOVOT 7670135IsraelISR
  • Phone+972 86264800
  • Fax+972 86264829
  • Websitehttps://wilkismilk.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Plantarc Bio Ltd4.74m-2.52m6.73m----0.6397--1.42-0.7559-0.75591.433.170.3709--15.95---19.71-37.73-21.54-41.7749.10---53.16-376.62----0.0109------57.69--111.75--
Millennium Food-Tech LP477.00k-42.14m12.92m2.00--0.1389--27.08-5.61-5.610.062914.220.0041--2.98238,500.00-36.10---36.33-------8,833.96-----0.04180.00--224.48---84.01------
Wilk Technologies Ltd0.00-9.52m30.31m4.00--10.55-----0.1507-0.15070.000.04170.00-------60.36-266.55-71.74-298.65-------97,340.88---30.330.6091------36.02------
Grace Breeding Ltd466.00k-5.21m66.53m----33.18--142.77-1.40-1.300.12450.50030.15980.77181.22---193.35---199.58--80.04---1,210.30--3.49-225.080.00--121.53--23.10------
ICP Israel Citrus Plantations Ltd1.10m4.73m70.11m--16.601.1314.6663.7418.9218.924.40278.020.0123--0.995--5.288.115.528.2771.1870.30430.36521.38----0.00--4.011.78-78.1022.01-60.58--
Crookes Brothers Limited156.82m4.86m111.15m2.00k22.880.50864.470.70881.484.0247.6966.460.392--5.50--2.770.07713.570.0943--49.417.080.21341.924.370.2727--18.221.80112.96-2.49-16.13--
GFC Green Fields Capital Ltd0.0021.34m124.58m2.005.870.73835.84--2.112.110.0016.810.00------4.661.9913.483.58------------0.00------844.9045.32----
Data as of Sep 26 2024. Currency figures normalised to Wilk Technologies Ltd's reporting currency: Israeli Shekel ILS

Institutional shareholders

1.53%Per cent of shares held by top holders
HolderShares% Held
Meitav Mutual Funds Ltd.as of 30 Jun 2024413.71k0.60%
KSM Mutual Funds Ltd.as of 30 Jun 2024223.43k0.32%
Migdal Mutual Funds Ltd.as of 30 Jun 2024222.31k0.32%
Harel Mutual Funds Ltd.as of 30 Jun 2024135.10k0.20%
Psagot Mutual Funds Ltd.as of 30 Jun 202437.41k0.05%
Alumot Sprint Mutual Funds Management Ltd.as of 27 Jun 202418.26k0.03%
IBI Mutual Funds Management (1978) Ltd.as of 27 Jun 20243.03k0.00%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.